# AMPLIMED CORP: Form D filings

AMPLIMED CORP, a biotechnology company in Tucson, AZ, filed 6 Form D notices with the SEC between 2009 and 2010. The latest, on March 3, 2010, reports $7.1 million sold of a $12 million offering to 11 investors.

Find out what AMPLIMED CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20AMPLIMED%20CORP%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=AMPLIMED%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Famplimed-corp-866105)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20AMPLIMED%20CORP%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=AMPLIMED%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Famplimed-corp-866105)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Arizona](https://specstream.ai/data/form-d/state/arizona): 953 rows, by operating companies, filed since November 1, 2024, $47.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/arizona
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4380 NORTH CAMPBELL AVENUE, SUITE 205, Tucson, AZ, 85718
- Phone: (520) 529-1000
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506, Securities Act section 4(6)
- SEC identifier (CIK): 866105

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 3, 2010 | Amendment | $12,000,000 | $7,142,093 | $4,857,907 | 11 | Aug 17, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/866105/000086610510000002/0000866105-10-000002-index.htm) |
| Jan 8, 2010 | Amendment | $12,000,000 | $6,604,443 | $5,395,557 | 11 | Aug 17, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/866105/000086610510000001/0000866105-10-000001-index.htm) |
| Dec 24, 2009 | Amendment | $12,000,000 | $5,649,443 | $6,350,557 | 10 | Aug 17, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/866105/000086610509000007/0000866105-09-000007-index.htm) |
| Sep 22, 2009 | Amendment | $12,000,000 | $3,919,043 | $8,080,957 | 8 | Aug 17, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/866105/000086610509000006/0000866105-09-000006-index.htm) |
| Aug 31, 2009 | New notice | $12,000,000 | $3,689,043 | $8,310,957 | 8 | Aug 17, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/866105/000086610509000005/0000866105-09-000005-index.htm) |
| Apr 30, 2009 | Amendment | $2,500,000 | $1,998,340 | $501,660 | 7 | Nov 21, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/866105/000086610509000003/0000866105-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Chris Richied | Executive Officer |  |
| Randolph T. Steer | Director |  |
| Joel A. Smolen | Director |  |
| John M. Holliman | Director |  |
| Ronald M. Garren | Director |  |
| William T. Remers | Executive Officer |  |
| Harry A. George | Director |  |
| Steve T. Steinman | Executive Officer |  |
| Robert T. Dorr | Executive Officer, Director |  |

## Other biotechnology companies in Arizona that filed recently

- [Gut-Brain-Axis Therapeutics Inc.](https://specstream.ai/data/form-d/company/gut-brain-axis-therapeutics-inc-1996678) $2 million · Oct 27, 2026
- [Avery Therapeutics, Inc.](https://specstream.ai/data/form-d/company/avery-therapeutics-inc-1708135) $8.5 million · Sep 21, 2026

[Every Form D from the week of Mar 1, 2010](https://specstream.ai/data/form-d/week/2010-03-01) · [All recent filings in Arizona](https://specstream.ai/data/form-d/state/arizona) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what AMPLIMED CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).